VYNDAQEL- tafamidis meglumine capsule, liquid filled
VYNDAMAX- tafamidis capsule, liquid filled
Pfizer Laboratories Div Pfizer Inc
----------
This Patient Information has been approved by the U.S. Food and Drug Administration | Issued: 04/2020 |
PATIENT INFORMATION | |
VYNDAQEL® (VIN-duh-kel) (tafamidis meglumine) capsules | VYNDAMAX™ (VIN-dah-max) (tafamidis) capsules |
What is VYNDAQEL and VYNDAMAX? VYNDAQEL and VYNDAMAX are prescription medicines used to treat adults with cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) to reduce death and hospitalization related to heart problems. It is not known if VYNDAQEL and VYNDAMAX are safe and effective in children. | |
Before taking VYNDAQEL or VYNDAMAX, tell your healthcare provider about all your medical conditions, including if you:
| |
How should I take VYNDAQEL or VYNDAMAX?
| |
What are the possible side effects of VYNDAQEL and VYNDAMAX? There were no known side effects that happened during treatment with VYNDAQEL or VYNDAMAX in people with cardiomyopathy of transthyretin-mediated amyloidosis. You may report side effects to FDA at 1-800-FDA-1088. | |
How should I store VYNDAQEL and VYNDAMAX?
| |
General information about the safe and effective use of VYNDAQEL and VYNDAMAX. Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use VYNDAQEL or VYNDAMAX for a condition for which it was not prescribed. Do not give VYNDAQEL or VYNDAMAX to other people, even if they have the same symptoms you have. It may harm them. You can ask your healthcare provider or pharmacist for information about VYNDAQEL or VYNDAMAX that is written for healthcare professionals. | |
What are the ingredients in VYNDAQEL and VYNDAMAX? VYNDAQEL: Active ingredient: tafamidis meglumine Inactive ingredients: ammonium hydroxide 28%, brilliant blue FCF, carmine, gelatin, glycerin, iron oxide (yellow), polyethylene glycol 400, polysorbate 80, polyvinyl acetate phthalate, propylene glycol, sorbitan monooleate, sorbitol, and titanium dioxide VYNDAMAX: Active ingredient: tafamidis Inactive ingredients: ammonium hydroxide 28%, butylated hydroxytoluene, gelatin, glycerin, iron oxide (red), polyethylene glycol 400, polysorbate 20, povidone (K-value 90), polyvinyl acetate phthalate, propylene glycol, sorbitol, and titanium dioxide LAB-0573-3.0 For more information, go to www.vyndaqel.com or call 1-800-438-1985. |